Chief Technology Officer Synthetic Genomics Inc.
Dr. James (Jim) Flatt joined Synthetic Genomics Inc. (SGI) in 2010 as the Chief Technology Officer. SGI is a leader in the development and application of synthetic biology technology for sustainable production of fuels and chemicals and application in agriculture. Since 2013, Jim has served as President of Genovia Bio, which is responsible for the development of algal-based solutions for food fuels and chemicals markets. Jim has been involved in the industrial biotechnology field for over 20 years. Just prior to SGI, Jim was the Executive Vice President of Research & Development and Operations at Mascoma Corporation, a leader in the development of cellulosic biofuels. Prior to Mascoma. Jim served as Sr. Vice President of Research for Martek Biosciences Corporation (Columbia, MD), leading the development of nutritional fatty acids from microalgae which are now included in many infant formula and food products. Prior to Martek, Jim was involved in microbial biotechnology research at Merck and Monsanto.
Jim received his undergraduate degree in Chemical Engineering from Massachusetts Institute of Technology and graduate degrees in Chemical Engineering from the University of California-Berkeley and University of Wisconsin-Madison. Jim served as the Chairman of the Industrial Advisory Board for the National Science Foundation Engineering Research Center for Marine Biotechnology (MarBEC) at the Universities of Hawaii and California-Berkeley.